
The ABPI has fired its latest salvo in the clinical trial transparency debate by announcing it will appoint a new …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

